NS

Nilu Singh

Active Director Director DIN 07636466
DIN 07636466 First appointment Dec 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value •••• Premium profile

About Nilu Singh

Data last updated:

Nilu Singh is a Director at Triomed Health Care Private Limited (since 2016). The company operates in Chemicals. Triomed Health Care Private Limited reported revenue of ₹34.9 Lakh (FY 2025).

DIN 07636466
Primary Designation Director
Industry Chemicals
First Appointment 21 Dec 2016
Oldest Company Age 9 yrs
Largest company Triomed Health Care Private Limited · ₹34.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Triomed Health Care Private Limited U24110MH2016PTC288727
Director21 Dec 20162016₹34.9 Lakh (FY 2025)Active

Board colleagues of Nilu Singh

Directorship timeline

Open interactive timeline →
Triomed Health Care Private Limited
Premium access

Shareholding and investment profile for Nilu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilu Singh

Nilu Singh currently holds 1 directorship: Triomed Health Care Private Limited (Director, since 21 Dec 2016, revenue ₹34.9 Lakh (FY 2025)).

Nilu Singh was first appointed on 21 Dec 2016 as Director at Triomed Health Care Private Limited.

The current boards of Nilu Singh's companies include Madhulika (Triomed Health Care Private Limited), Priyanka Priya (Triomed Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available